T. Ekblad
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- Physiology top 5%
- Calcium signaling and nucleotide metabolism
Papers in
- Oncology 9
- PARP inhibition in cancer therapy 9
-
- Chemical Synthesis and Analysis 3
- Cell death mechanisms and regulation 2
- Co-authors
- H. Schüler (12 shared papers)T. Karlberg (6 shared papers)Antonio Macchiarulo (2 shared papers)A.G. Thorsell (5 shared papers)A.F. Pinto (2 shared papers)Johan Weigelt (4 shared papers)M. Moche (1 shared paper)Michael S. Cohen (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)European Journal of Nuclear Medicine and Molecular Imaging (2 papers)FEBS Journal (1 paper)European Journal of Medicinal Chemistry (1 paper)Bioconjugate Chemistry (1 paper)
- Partner nations
- SwedenSwitzerlandCanada
In The Last Decade
T. Ekblad
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 71
- Oncology 785
- Physiology 103
- Immunology 220
- Radiology, Nuclear Medicine and Imaging 222
- Molecular Biology 654
Countries citing papers authored by T. Ekblad
This map shows the geographic impact of T. Ekblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Ekblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Ekblad more than expected).
Fields of papers citing papers by T. Ekblad
This network shows the impact of papers produced by T. Ekblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Ekblad. The network helps show where T. Ekblad may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Ekblad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 386 | |
| 2 | 2016 | 278 | |
| 3 | 2015 | 82 | |
| 4 | 2008 | 69 | |
| 5 | 2013 | 66 | |
| 6 | 2015 | 55 | |
| 7 | 2013 | 49 | |
| 8 | 2015 | 43 | |
| 9 | 2008 | 42 | |
| 10 | 2009 | 36 | |
| 11 | 2012 | 35 | |
| 12 | 2018 | 22 | |
| 13 | 2015 | 16 | |
| 14 | 2009 | 14 | |
| 15 | 2015 | 14 | |
| 16 | 2009 | 14 | |
| 17 | 2013 | 11 |
About T. Ekblad
T. Ekblad is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Electrical and Electronic Engineering, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (9 papers), Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Chemical Synthesis and Analysis (3 papers), Electrostatic Discharge in Electronics (3 papers), Click Chemistry and Applications (2 papers), Cell death mechanisms and regulation (2 papers) and Integrated Circuits and Semiconductor Failure Analysis (2 papers). The work is most often cited by research in Oncology (785 citations), Physiology (103 citations), Immunology (220 citations), Radiology, Nuclear Medicine and Imaging (222 citations) and Molecular Biology (654 citations). T. Ekblad has collaborated with scholars based in Sweden, Switzerland and Canada. Frequent co-authors include H. Schüler, T. Karlberg, Antonio Macchiarulo, A.G. Thorsell, A.F. Pinto, Johan Weigelt, M. Moche, Michael S. Cohen, A.G. Thorsell and L. Tresaugues. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Nuclear Medicine and Molecular Imaging, FEBS Journal, European Journal of Medicinal Chemistry and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.